GATA-3 expression in trophoblastic tissues: An immunohistochemical study of 445 cases, including diagnostic utility

American Journal of Surgical Pathology

Volumn 39, Issue 1, 2015, Pages 101-108

  Banet, Natalie ^a   Gown, Allen M ^b   Shih, Ie Ming ^a,c,d   Li, Qing Kay ^e   Roden, Richard B S ^a   Nucci, Marisa R ^d   Cheng, Liang ^f   Przybycin, Christopher G ^g   Nasseri Nik, Niloofar ^h   Wu, Lee Shu Fune ⁱ   Netto, George J ^j   Ronnett, Brigitte M ^a,c   Vang, Russell ^a,c  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b Department of Pathology   (United States)

^c Reproductive Sciences   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^f PHENOPATH LABORATORIES   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ LERNER RESEARCH INSTITUTE   (United States)

^j South Miami Hospital   (United States)

more..

Author keywords

Choriocarcinoma; GATA 3; Leiomyosarcoma; Squamous cell carcinoma; Trophoblast

Indexed keywords

GATA3 PROTEIN, HUMAN; TRANSCRIPTION FACTOR GATA 3; TUMOR MARKER;

BIOPSY; CHEMISTRY; DIFFERENTIAL DIAGNOSIS; EVALUATION STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; PATHOLOGY; PREDICTIVE VALUE; PREGNANCY; PROGNOSIS; TISSUE MICROARRAY; TROPHOBLASTIC TUMOR;

BIOMARKERS, TUMOR; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FEMALE; GATA3 TRANSCRIPTION FACTOR; GESTATIONAL TROPHOBLASTIC DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; PREDICTIVE VALUE OF TESTS; PREGNANCY; PROGNOSIS; TISSUE ARRAY ANALYSIS; TROPHOBLASTIC NEOPLASMS;

EID: 84919385192     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000315     Document Type: Article

References (32)

1. Ordóñez NG. Value of GATA3 immunostaining in tumor diagnosis: a review. Adv Anat Pathol. 2013;20:352-360.
2. Liu H, Shi J, Wilkerson ML, et al. Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas. Am J Clin Pathol. 2012;138:57-64.
3. Higgins JP, Kaygusuz G, Wang L, et al. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. Am J Surg Pathol. 2007;31:673-680.
4. Miettinen M, McCue PA, Sarlomo-Rikala M, et al. GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. Am J Surg Pathol. 2014;38:13-22.
5. Gulbahce HE, Sweeney C, Surowiecka M, et al. Significance of GATA-3 expression in outcomes of patients with breast cancer who received systemic chemotherapy and/or hormonal therapy and clinicopathologic features of GATA-3-positive tumors. Hum Pathol. 2013;44:2427-2431.
6. Albergaria A, Paredes J, Sousa B, et al. Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours. Breast Cancer Res. 2009;11:R40.
7. Yoon NK, Maresh EL, Shen D, et al. Higher levels of GATA3 predict better survival in women with breast cancer. Hum Pathol. 2010;41:1794-1801.
8. Cimino-Mathews A, Subhawong AP, Illei PB, et al. GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas. Hum Pathol. 2013;44:1341-1349.
9. Schwartz LE, Begum S, Westra WH, et al. GATA3 immunohistochemical expression in salivary gland neoplasms. Head Neck Pathol. 2013;7:311-315.
10. Shih IM, Kurman RJ. Expression of melanoma cell adhesion molecule in intermediate trophoblast. Lab Invest. 1996;75:377-388.
11. Mao TL, Kurman RJ, Huang CC, et al. Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis. Am J Surg Pathol. 2007;31:1726-1732.
12. Singer G, Kurman RJ, McMaster MT, et al. HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis. Am J Surg Pathol. 2002;26:914-920.
13. Mao TL, Kurman RJ, Jeng YM, et al. HSD3B1 as a novel trophoblast-associated marker that assists in the differential diagnosis of trophoblastic tumors and tumorlike lesions. Am J Surg Pathol. 2008;32:236-242.
14. Chou YY, Jeng YM, Mao TL. HSD3B1 is a specific trophoblastassociated marker not expressed in a wide spectrum of tumors. Int J Gynecol Cancer. 2013;23:343-347.
15. Shih IeM. Trophogram, an immunohistochemistry-based algorithmic approach, in the differential diagnosis of trophoblastic tumors and tumorlike lesions. Ann Diagn Pathol. 2007;11:228-234.
16. Chang A, Brimo F, Montgomery EA, et al. Use of PAX8 and GATA3 in diagnosing sarcomatoid renal cell carcinoma and sarcomatoid urothelial carcinoma. Hum Pathol. 2013;44:1563-1568.
17. Chang A, Amin A, Gabrielson E, et al. Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung. Am J Surg Pathol. 2012;36: 1472-1476.
18. Chaux A, Han JS, Lee S, et al. Immunohistochemical profile of the penile urethra and differential expression of GATA3 in urothelial versus squamous cell carcinomas of the penile urethra. Hum Pathol. 2013;44:2760-2767.
19. Gruver AM, Amin MB, Luthringer DJ, et al. Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung. Arch Pathol Lab Med. 2012;136:1339-1346.
20. Steenbergen RD, OudeEngberink VE, Kramer D, et al. Downregulation of GATA-3 expression during human papillomavirusmediated immortalization and cervical carcinogenesis. Am J Pathol. 2002;160:1945-1951.
21. Chew I, Post MD, Carinelli SG, et al. p16 expression in squamous and trophoblastic lesions of the upper female genital tract. Int J Gynecol Pathol. 2010;29:513-522.
22. Mao TL, Seidman JD, Kurman RJ, et al. Cyclin E and p16 immunoreactivity in epithelioid trophoblastic tumor-an aid in differential diagnosis. Am J Surg Pathol. 2006;30:1105-1110.
23. Kalhor N, Ramirez PT, Deavers MT, et al. Immunohistochemical studies of trophoblastic tumors. Am J Surg Pathol. 2009;33: 633-638.
24. Assou S, Boumela I, Haouzi D, et al. Transcriptome analysis during human trophectoderm specification suggests new roles of metabolic and epigenetic genes. PLoS One. 2012;7:e39306.
25. Bai H, Sakurai T, Someya Y, et al. Regulation of trophoblastspecific factors by GATA2 and GATA3 in bovine trophoblast CT- 1 cells. J Reprod Dev. 2011;57:518-525.
26. Home P, Ray S, Dutta D, et al. GATA3 is selectively expressed in the trophectoderm of peri-implantation embryo and directly regulates Cdx2 gene expression. J Biol Chem. 2009;284: 28729-28737.
27. Ma GT, Roth ME, Groskopf JC, et al. GATA-2 and GATA-3 regulate trophoblast-specific gene expression in vivo. Development. 1997;124:907-914.
28. Piao YS, Peltoketo H, Vihko P, et al. The proximal promoter region of the gene encoding human 17beta-hydroxysteroid dehydrogenase type 1 contains GATA. AP-2, and Sp1 response elements: analysis of promoter function in choriocarcinoma cells. Endocrinology. 1997;138:3417-3425.
29. Ralston A, Cox BJ, Nishioka N, et al. Gata3 regulates trophoblast development downstream of Tead4 and in parallel to Cdx2. Development. 2010;137:395-403.
30. Ray S, Dutta D, Rumi MA, et al. Context-dependent function of regulatory elements and a switch in chromatin occupancy between GATA3 and GATA2 regulate Gata2 transcription during trophoblast differentiation. J Biol Chem. 2009;284:4978-4988.
31. Saben J, Zhong Y, McKelvey S, et al. A comprehensive analysis of the human placenta transcriptome. Placenta. 2014;35:125-131.
32. Ng YK, George KM, Engel JD, et al. GATA factor activity is required for the trophoblast-specific transcriptional regulation of the mouse placental lactogen I gene. Development. 1994;120: 3257-3266.